Zepp Health Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZEPP research report →
Range $12 – $12
Price Chart
About the company
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories.
- CEO
- Wang Huang
- IPO
- 2018
- Employees
- 763
- HQ
- Gorinchem, GR, NL
Get TickerSpark's AI analysis on ZEPP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $55.93M
- P/E
- -0.09
- Fwd P/E
- 11.17
- PEG
- 0.00
- P/S
- 0.19
- P/B
- 0.02
- EV/EBITDA
- -5.26
- Div Yield
- 0.00%
- Gross Margin
- 39.12%
- Op Margin
- -12.43%
- Net Margin
- -15.64%
- ROE
- -27.93%
- ROIC
- -8.14%
Latest fiscal year · YoY change
- Revenue
- $1.82B+36.1%
- Gross Profit
- $711.63M+38.8%
- Op Income
- $-204,934,260
- Net Income
- $-280,920,495+49.3%
- EPS
- $-283.04-730.5%
- OCF Growth
- -636.5%
- FCF Growth
- -615.3%
- 52W High
- $61.85
- 52W Low
- $3.63
- 50D MA
- $4.69
- 200D MA
- $12.50
- Beta
- 1.81
- RSI (14)
- 36
- Avg Volume
- 41.08K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Zepp Health posted a strong Q1 with 33.8% revenue growth, margin expansion, and continued premiumization momentum, while guiding Q2 revenue to $63 million-$68 million amid higher memory costs and launch timing shifts.· September 1, 2026
- Q1 revenue was $51.5 million, up 33.8% year over year, driven by ActiveMax, Active 3 Premium, and T-Rex Ultra 2 launches.
- Gross margin was 37.7%, up 0.4 points year over year, despite higher memory costs and FX pressure.
- Management said average selling price rose more than 20% year over year and premium T-Rex models made up nearly 50% of T-Rex unit sales in March-April.
- The company expanded its HYROX partnership into a new exclusive 3-year global deal to deepen its position in hybrid training.
- Q2 revenue guidance is $63 million-$68 million, implying 6%-14% year-over-year growth, but management flagged shipment timing and product launch phasing as factors.
Q1 2026 revenue was $51.5 million, up 33.8% year over year. Gross margin was 37.7%, up 0.4 points from Q1 2025, and gross profit rose 35.3% to $19.4 million. Operating loss narrowed to $6.3 million from $17.2 million a year ago, and adjusted net loss was $17.9 million, or 34.8% of sales, versus $18.1 million, or 41% of sales, in Q1 2025. Inventory ended at $62.8 million and cash and cash equivalents were $103.2 million. For Q2 2026, Zepp guided revenue to $63 million-$68 million, or about 6%-14% growth year over year. Management said the outlook reflects demand across the portfolio but also normal shipment timing and product launch phasing; no full-year revenue guidance was given, though they said they expect profitable growth over 2025.
CEO Wang Huang framed the quarter as validation of a structural shift toward hybrid training, premium products, and stronger brand positioning. He said Amazfit is evolving into a comprehensive hybrid training platform across endurance, strength, recovery, hardware, AI training intelligence, software, and data, and highlighted the new exclusive 3-year HYROX partnership as a strategic move to build authority in the emerging category. His tone was confident and strategic, emphasizing premiumization, pricing power, and a path toward long-term profitability.
CFO Leon Deng focused on the financial mechanics behind the quarter: revenue of $51.5 million, gross margin of 37.7%, and gross profit of $19.4 million. He said adjusted operating expenses were $35.7 million, operating loss was $6.3 million, adjusted net loss was $17.9 million, inventory was $62.8 million, and cash and cash equivalents were $103.2 million. He also flagged near-term gross margin pressure from higher memory costs, said the company is preparing through diversified sourcing and engineering changes, and reiterated capital discipline, including $46.7 million of debt retired since the beginning of 2023 and $17 million of the $20 million share repurchase authorization completed by March 31, 2026.
Analysts pressed management on how many new product launches remain this year, whether cost cuts can offset higher spending, and how Zepp will handle rising memory costs. Leon said there will likely be more than 9 launches in 2026, with launch-heavy first-half spending expected to normalize later in the year, and he suggested quarterly operating expenses could step down toward a roughly $30 million run rate or lower. On pricing, he said competitors are also raising prices and Zepp has room to do so, but the company still wants to deliver the best product and experience at the best price. On HYROX monetization, management said the partnership is meant to deepen product relevance for serious athletes and build brand authority so Amazfit becomes the choice when users move into more serious training.
The call showed clear momentum in both growth and mix: revenue rose 33.8%, ASP increased more than 20%, and gross margin expanded despite component and FX headwinds. Management also said premium T-Rex models are gaining traction, Amazfit is gaining value share in EMEA, the U.S., and Asia Pacific, and the HYROX partnership could strengthen the brand’s position in hybrid training.
Management acknowledged a real near-term margin risk from rising memory costs tied to DDR4-to-DDR5 and HBM supply tightness, plus some FX pressure. Q2 guidance also appears partly constrained by shipment timing and launch phasing, and the company did not provide full-year financial guidance, only saying it expects profitable growth over 2025.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 100.0%
- Shares Outstanding
- 14.32M
- Float Shares
- 14.32M
of shares held by institutions
34 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 741.83K | ▲ 34.14K |
| Fil Ltd | 718.18K | ▲ 826 |
| Point72 Hong Kong Ltd | 548.56K | ▲ 548.56K |
| Price T Rowe Associates Inc | 311.85K | ▼ 59 |
| Yiheng Capital Management, L.P. | 220.50K | ▲ 162.77K |
| Allspring Global Investments Holdings, LLC | 46.75K | 0 |
| Citigroup Inc | 40.00K | 0 |
| Mirae Asset Global Etfs Holdings Ltd. | 30.31K | ▼ 882 |
| Marshall Wace, Llp | 26.15K | ▲ 26.15K |
| Susquehanna International Group, Llp | 23.87K | ▲ 23.87K |
| Ubs Group AG | 22.57K | ▼ 11.75K |
| Engineers Gate Manager LP | 20.92K | ▲ 6.43K |
Held by 9 ETFs
Biggest fund positions in ZEPP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 23, 26 | Yu Pengtao | sell | 5,749 |
| Sep 24, 26 | Yu Pengtao | sell | 4,251 |
| Jun 26, 26 | FAN Meihui | other | 520,000 |
| Jun 26, 26 | FAN Meihui | other | 80,000 |
| Apr 1, 26 | Deng Cheng | other | 366,000 |
| Jun 26, 26 | Deng Cheng | other | 22,875 |
| Jun 26, 26 | Deng Cheng | sell | 9,836 |
| Jun 26, 26 | Deng Cheng | other | 366,000 |
| Mar 17, 26 | Xie Bing (Brian) | other | 0 |
| Mar 17, 26 | Lai Jimmy Y. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ZEPP coverage
Recent articles, reports, and earnings notes.
No research on ZEPP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZEPP report →Zepp Health Corporation (ZEPP) Q2 2026 Earnings Call Transcript
seekingalpha.com · Sep 2
Zepp Health Q2 Earnings Call Highlights
marketbeat.com · Sep 1
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
gurufocus.com · Sep 1
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
prnewswire.com · Sep 1
Zepp Health Corporation to Report Second Quarter 2026 Financial Results on September 1, 2026
prnewswire.com · Aug 19
Amazfit Brings Interactive iOS Notifications to Select Smartwatches in Europe
businesswire.com · Jun 25
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training
businesswire.com · Jun 18
Why These High-Flying Stocks Came Back To Earth
benzinga.com · Jun 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.